claim
Prospective studies have shown an association between elevated myeloperoxidase (MPO) levels and future cardiovascular event risk in healthy individuals and patients with stable and unstable coronary artery disease (CAD), though other studies have found MPO to be less predictive.

Authors

Sources

Referenced by nodes (2)